HUP0004170A2 - Eljárás és anyagok nyálkaszövetek gyulladásának kezelésére és megelőzésére - Google Patents
Eljárás és anyagok nyálkaszövetek gyulladásának kezelésére és megelőzéséreInfo
- Publication number
- HUP0004170A2 HUP0004170A2 HU0004170A HUP0004170A HUP0004170A2 HU P0004170 A2 HUP0004170 A2 HU P0004170A2 HU 0004170 A HU0004170 A HU 0004170A HU P0004170 A HUP0004170 A HU P0004170A HU P0004170 A2 HUP0004170 A2 HU P0004170A2
- Authority
- HU
- Hungary
- Prior art keywords
- materials
- induced
- fungi
- methods
- prevention
- Prior art date
Links
- 239000000463 material Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 241000233866 Fungi Species 0.000 abstract 5
- 208000015181 infectious disease Diseases 0.000 abstract 3
- 230000002458 infectious effect Effects 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 3
- 201000009890 sinusitis Diseases 0.000 abstract 3
- 206010028116 Mucosal inflammation Diseases 0.000 abstract 2
- 201000010927 Mucositis Diseases 0.000 abstract 2
- 229940121375 antifungal agent Drugs 0.000 abstract 2
- 210000003097 mucus Anatomy 0.000 abstract 2
- 230000002062 proliferating effect Effects 0.000 abstract 2
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 208000023819 chronic asthma Diseases 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 208000024035 chronic otitis media Diseases 0.000 abstract 1
- 206010009887 colitis Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Biotechnology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
Abstract
InterLn=1386;>(57) A találmány eljárásokkal és anyagokkal foglalkoziknem terjedő gombák által indukált mukozitisz kezelésére ésmegelőzésére. Pontosabban a találmány gombaellenes szerek beadásávalfoglalkozik úgy, hogy ezek érintkezésbe lépjenek a nyálkával olyanmennyiségben, gyakorisággal és időtartamon át, amely hatékony a nemterjedő gomba által indukált rinoszinuszitisz megelőzésére,csökkentésére vagy eltüntetésére. A találmány eljárásokat és anyagokatis nyújt nem terjedő gomba által indukált rinoszinuszitiszdiagnosztizálására és nem terjedő gombák kitenyésztésére emlősöknyálka mintáiból, továbbá speciális gombaellenes kiszereléseket ésorvosi berendezéseket nyújt nem terjedő gomba által indukáltrinoszinuszitisz kezelésére és megelőzésére. A találmány továbbáeljárásokat és anyagokat biztosít más nem-terjedő gomba által indukáltmukozitiszes állapotok kezelésére és megelőzésére is, ilyenek példáula krónikus középfülgyulladás, krónikus vastagbélgyulladás és Crohn-féle betegség. A találmány továbbá eljárásokat és anyagokat biztosít akrónikus asztma tüneteinek kezelésére és megelőzésére. Ó
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6270997P | 1997-10-22 | 1997-10-22 | |
US6341497P | 1997-10-28 | 1997-10-28 | |
US6341897P | 1997-10-28 | 1997-10-28 | |
US8327298P | 1998-04-28 | 1998-04-28 | |
US8639798P | 1998-05-22 | 1998-05-22 | |
PCT/US1998/022403 WO1999020261A2 (en) | 1997-10-22 | 1998-10-22 | Use of antigunal agents for the topial treatment of fungus-induced mucositis |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0004170A2 true HUP0004170A2 (hu) | 2001-05-28 |
HUP0004170A3 HUP0004170A3 (en) | 2001-12-28 |
Family
ID=27535591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004170A HUP0004170A3 (en) | 1997-10-22 | 1998-10-22 | Methods and materials for treating and preventing inflammation ofmucosal tissue |
Country Status (28)
Country | Link |
---|---|
US (9) | US6291500B2 (hu) |
EP (2) | EP1024814B1 (hu) |
JP (3) | JP2001520188A (hu) |
KR (4) | KR20010031363A (hu) |
CN (1) | CN1143679C (hu) |
AP (1) | AP2000001805A0 (hu) |
AT (1) | ATE371457T1 (hu) |
AU (1) | AU1195999A (hu) |
BG (1) | BG104371A (hu) |
BR (1) | BR9814615A (hu) |
CA (1) | CA2308201C (hu) |
DE (1) | DE69838338T2 (hu) |
DK (1) | DK1024814T3 (hu) |
EA (1) | EA200000439A1 (hu) |
EE (1) | EE200000253A (hu) |
ES (1) | ES2292210T3 (hu) |
HK (1) | HK1029935A1 (hu) |
HU (1) | HUP0004170A3 (hu) |
ID (1) | ID26104A (hu) |
IL (2) | IL135774A0 (hu) |
IS (1) | IS5463A (hu) |
NO (1) | NO325714B1 (hu) |
OA (1) | OA11351A (hu) |
PL (1) | PL340606A1 (hu) |
PT (1) | PT1024814E (hu) |
SK (1) | SK5732000A3 (hu) |
TR (1) | TR200001117T2 (hu) |
WO (1) | WO1999020261A2 (hu) |
Families Citing this family (141)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6045815A (en) * | 1997-08-15 | 2000-04-04 | Board Of Regents, The University Of Texas System | Parenteral pimaricin as treatment of systemic infections |
US6844004B2 (en) | 1997-08-15 | 2005-01-18 | Board Of Regents, The University Of Texas System | Topical formulations of natamycin/pimaricin |
PT1024814E (pt) * | 1997-10-22 | 2007-11-29 | Mayo Foundation | Utilização de agentes antifúngicos para o tratamento tópico de mucosite induzida por fungo |
GB9826656D0 (en) | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
AU5975700A (en) * | 1999-07-02 | 2001-01-22 | Janssen Pharmaceutica N.V. | Nasal formulation of an antifungal |
US6576224B1 (en) * | 1999-07-06 | 2003-06-10 | Sinuspharma, Inc. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
US20020061281A1 (en) * | 1999-07-06 | 2002-05-23 | Osbakken Robert S. | Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
SE521431C2 (sv) * | 1999-12-02 | 2003-11-04 | Sca Hygiene Prod Ab | Användning av en pH-buffrande substans för att förhindra hudinfektioner orsakade av Candida Albicans |
AU2001232787A1 (en) * | 2000-01-14 | 2001-07-24 | University Of Virginia Patent Foundation | Airway alkalinization as therapy for airway diseases |
AU2001236448A1 (en) * | 2000-02-18 | 2001-08-27 | Eli Lilly And Company | Methods of treatment for non-invasive fungus-induced mucositis with cyclohexapeptide antifungal agents |
US7150888B1 (en) | 2000-04-03 | 2006-12-19 | Inhalation, Inc. | Methods and apparatus to prevent colds, influenzaes, tuberculosis and opportunistic infections of the human respiratory system |
US7048953B2 (en) * | 2000-04-03 | 2006-05-23 | Inhalation, Inc. | Methods and apparatus to prevent, treat and cure infections of the human respiratory system by pathogens causing severe acute respiratory syndrome (SARS) |
US8404217B2 (en) * | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US6767537B2 (en) | 2000-05-26 | 2004-07-27 | Phil Arnold Nicolay | Composition and method for the treatment of sinusitis |
WO2002007682A1 (en) * | 2000-07-26 | 2002-01-31 | Vyden John K | Methods for treating atopic disorders |
EP1239853B1 (de) * | 2000-09-14 | 2006-11-08 | Waldemar Gottardi | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen |
JP4822652B2 (ja) * | 2000-11-22 | 2011-11-24 | エンド ファーマシューティカルズ インコーポレイテッド | 粘膜炎の治療 |
JP2004517127A (ja) | 2000-12-21 | 2004-06-10 | ネクター セラピューティックス | ポリエン抗真菌剤の肺送達 |
US7770577B2 (en) * | 2001-05-15 | 2010-08-10 | Gregory E Conner | Methods and devices for treating lung dysfunction |
JPWO2002098463A1 (ja) * | 2001-06-05 | 2004-09-16 | 財団法人新産業創造研究機構 | 抗真菌組成物 |
US7244703B2 (en) * | 2001-06-22 | 2007-07-17 | Bentley Pharmaceuticals, Inc. | Pharmaceutical compositions and methods for peptide treatment |
AUPS017702A0 (en) * | 2002-01-25 | 2002-02-14 | Atopic Pty Ltd | Methods and compositions for the treatment of asthma and related disorders |
US20040019316A1 (en) * | 2002-03-13 | 2004-01-29 | Morris John K. | Nasal airway delivery, decongestion system (NADDS) |
AU2003259028A1 (en) * | 2002-06-10 | 2003-12-22 | Combinatorx, Incorporated | Combinations for the treatment of rheumatoid arthritis |
WO2004000272A1 (en) * | 2002-06-20 | 2003-12-31 | Novartis Consumer Health S.A. | Nasal compositions comprising a mucopolysaccharide and propylene glycol |
US20050032896A1 (en) * | 2002-06-21 | 2005-02-10 | Liisa Neumann | Use of synthetic retinoic acid in form of 13-cis vitamin A for treatment of autism |
WO2004004700A1 (en) * | 2002-07-02 | 2004-01-15 | Novartis Ag | Methods for the treatment of sinusitis |
US20040029893A1 (en) * | 2002-07-23 | 2004-02-12 | Lane Edward M. | Method of treatment of non-invasive mucositis |
ES2494791T3 (es) | 2002-09-18 | 2014-09-16 | Trustees Of The University Of Pennsylvania | Uso de rapamicina para el tratamiento o prevención de la degeneración macular asociada a la edad |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
WO2004110346A2 (en) * | 2002-10-29 | 2004-12-23 | Transave, Inc. | Sustained release of antiinfectives |
WO2005000195A2 (en) * | 2002-11-13 | 2005-01-06 | Rosenberg Yvonne J | A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
US6890323B1 (en) * | 2002-12-03 | 2005-05-10 | University Of Florida | Small volume effusion trap |
CA2511555A1 (en) * | 2002-12-31 | 2004-07-22 | Nektar Therapeutics | Aerosolizable pharmaceutical formulation for fungal infection therapy |
US7544192B2 (en) | 2003-03-14 | 2009-06-09 | Sinexus, Inc. | Sinus delivery of sustained release therapeutics |
US9808471B2 (en) * | 2003-04-16 | 2017-11-07 | Mylan Specialty Lp | Nasal pharmaceutical formulations and methods of using the same |
US8912174B2 (en) | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
US7811606B2 (en) * | 2003-04-16 | 2010-10-12 | Dey, L.P. | Nasal pharmaceutical formulations and methods of using the same |
US20050043251A1 (en) * | 2003-08-20 | 2005-02-24 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
US20070078116A1 (en) * | 2003-08-20 | 2007-04-05 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
US20050159369A1 (en) * | 2003-08-20 | 2005-07-21 | Qtm Llc | Method of treatment of otitis externa |
US7749509B2 (en) * | 2003-08-29 | 2010-07-06 | Cobb And Company, Llp | Treatment of autism using probiotic composition |
US7731976B2 (en) * | 2003-08-29 | 2010-06-08 | Cobb And Company, Llp | Treatment of irritable bowel syndrome using probiotic composition |
US20060177424A1 (en) * | 2003-08-29 | 2006-08-10 | Cobb Mark L | Treatment of disease states and adverse physiological conditions utilizing anti-fungal compositions |
US7759105B2 (en) * | 2003-08-29 | 2010-07-20 | Cobb & Company, Llp | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
US8192733B2 (en) * | 2003-08-29 | 2012-06-05 | Cobb & Associates | Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
WO2005022998A2 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
EP1672989B1 (en) * | 2003-09-09 | 2012-04-25 | 3M Innovative Properties Company | Concentrated antimicrobial compositions and methods |
CA2538991A1 (en) | 2003-09-18 | 2005-03-31 | Children's Medical Center Corporation | Treatment of severe distal colitis |
KR100978717B1 (ko) | 2003-12-08 | 2010-08-30 | 씨펙스 파마슈티칼스, 인코포레이티드 | 인슐린 치료를 위한 약제 조성물 및 방법 |
US8741332B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for dermally treating neuropathic pain |
US20080019927A1 (en) * | 2004-06-07 | 2008-01-24 | Jie Zhang | Compositions and methods for dermally treating neuropathy with minoxidil |
US20070196293A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for treating photo damaged skin |
US20070189978A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Compositions and methods for dermally treating musculoskeletal pain |
US20070196325A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for dermally treating infections |
US8741333B2 (en) * | 2004-06-07 | 2014-06-03 | Nuvo Research Inc. | Compositions and methods for treating dermatitis or psoriasis |
US20070196453A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs |
US20070196457A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs |
US8907153B2 (en) | 2004-06-07 | 2014-12-09 | Nuvo Research Inc. | Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same |
US20070190124A1 (en) * | 2004-06-07 | 2007-08-16 | Jie Zhang | Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs |
US20070196452A1 (en) * | 2004-06-07 | 2007-08-23 | Jie Zhang | Flux-enabling compositions and methods for dermal delivery of drugs |
US20060009424A1 (en) * | 2004-07-06 | 2006-01-12 | Anatoly Kogan | Nasaleaze |
MY145148A (en) * | 2004-08-13 | 2011-12-30 | Schering Plough Ltd | Pharmaceutical formulation comprising an antibiotic, a triazole and a carticosteroid |
US9028852B2 (en) * | 2004-09-07 | 2015-05-12 | 3M Innovative Properties Company | Cationic antiseptic compositions and methods of use |
US8198326B2 (en) * | 2004-09-07 | 2012-06-12 | 3M Innovative Properties Company | Phenolic antiseptic compositions and methods of use |
US20060051384A1 (en) * | 2004-09-07 | 2006-03-09 | 3M Innovative Properties Company | Antiseptic compositions and methods of use |
KR100675379B1 (ko) * | 2005-01-25 | 2007-01-29 | 삼성전자주식회사 | 프린팅 시스템 및 프린팅 방법 |
US8109981B2 (en) | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
BRPI0608152A2 (pt) | 2005-02-09 | 2009-11-10 | Macusight Inc | formulações para tratamento ocular |
US20060229364A1 (en) * | 2005-03-10 | 2006-10-12 | 3M Innovative Properties Company | Antiviral compositions and methods of use |
US10918618B2 (en) * | 2005-03-10 | 2021-02-16 | 3M Innovative Properties Company | Methods of reducing microbial contamination |
CA2598985A1 (en) * | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Antimicrobial pet wipes and methods |
CN101137359B (zh) * | 2005-03-10 | 2011-01-12 | 3M创新有限公司 | 治疗耳感染的方法 |
AU2006223136A1 (en) * | 2005-03-10 | 2006-09-21 | 3M Innovative Properties Company | Antimicrobial compositions comprising esters of hydroxycarboxylic acids |
US8025635B2 (en) | 2005-04-04 | 2011-09-27 | Intersect Ent, Inc. | Device and methods for treating paranasal sinus conditions |
US7670849B2 (en) * | 2005-04-29 | 2010-03-02 | Henkin Robert I | Method for diagnosing insulin resistance from nasal secretions |
US8506934B2 (en) | 2005-04-29 | 2013-08-13 | Robert I. Henkin | Methods for detection of biological substances |
WO2007038466A2 (en) * | 2005-09-27 | 2007-04-05 | Cobb & Company | Treatment of bipolar disorder utilizing anti-fungal compositions |
ITRM20050561A1 (it) * | 2005-11-10 | 2007-05-11 | D M G Italia S R L | Soluzione otologica e metodo per la sua preparazione. |
AU2006320538B2 (en) * | 2005-11-30 | 2013-07-04 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
PT1962805T (pt) | 2005-12-08 | 2016-10-05 | Insmed Inc | Composições de anti-infeciosos baseadas em lípidos para tratamento de infeções pulmonares |
US20070226012A1 (en) * | 2005-12-13 | 2007-09-27 | Naryx Pharma, Inc. | Methods of measuring symptoms of chronic rhinosinusitis |
US8492400B2 (en) | 2006-02-09 | 2013-07-23 | Santen Pharmaceutical Co., Ltd. | Stable formulations, and methods of their preparation and use |
US20070219600A1 (en) * | 2006-03-17 | 2007-09-20 | Michael Gertner | Devices and methods for targeted nasal phototherapy |
JP5506378B2 (ja) | 2006-03-23 | 2014-05-28 | 参天製薬株式会社 | 血管透過性に関連する疾患または病気のための製剤および方法 |
US20100190735A1 (en) * | 2006-03-28 | 2010-07-29 | Myrex Pharmaceuticals Inc. | Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis |
WO2007117550A2 (en) * | 2006-04-06 | 2007-10-18 | Transave, Inc. | Methods for coacervation induced liposomal encapsulation and formulations thereof |
US20070280972A1 (en) * | 2006-04-25 | 2007-12-06 | Zars, Inc. | Adhesive solid gel-forming formulations for dermal drug delivery |
US20070286812A1 (en) * | 2006-06-09 | 2007-12-13 | Toutounghi Camille | Nasal formulation |
US20070286813A1 (en) * | 2006-06-09 | 2007-12-13 | Toutounghi Camille | Nasal formulation |
US8535707B2 (en) | 2006-07-10 | 2013-09-17 | Intersect Ent, Inc. | Devices and methods for delivering active agents to the osteomeatal complex |
US20080131420A1 (en) * | 2006-07-13 | 2008-06-05 | Accentia, Inc. | Methods and compositions for treating mucosal inflammation |
US20080075793A1 (en) * | 2006-09-21 | 2008-03-27 | Dunshee Wayne K | Antiviral compositions and methods of use |
US20080107723A1 (en) * | 2006-09-28 | 2008-05-08 | Perkins Walter R | Methods of Treating Pulmonary Distress |
EP2079306A4 (en) * | 2006-10-03 | 2009-12-30 | Accentia Biopharmaceuticals In | NON-MOLECULE-BREAKING AMPHOTERICIN B FORMULATIONS AND METHOD FOR TREATING NON-INVASIVE PULSE-INDUCED MUCOSITIS |
CN101489379B (zh) | 2006-10-27 | 2014-06-04 | 3M创新有限公司 | 抗微生物组合物 |
US20110146671A1 (en) * | 2006-12-01 | 2011-06-23 | James Zhou Liu | Pharmaceutical compositions and methods of delivering the same |
US8293489B2 (en) | 2007-01-31 | 2012-10-23 | Henkin Robert I | Methods for detection of biological substances |
WO2008134721A1 (en) * | 2007-04-30 | 2008-11-06 | Smithkline Beecham Corporation | Methods for administering anti-il-5 antibodies |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
DK2231065T3 (da) | 2007-12-18 | 2021-02-01 | Intersect Ent Inc | Selvekspanderende anordninger |
CN101214221A (zh) * | 2007-12-27 | 2008-07-09 | 黄明 | 治疗鼻炎鼻窦炎药物制剂 |
US9314524B2 (en) * | 2007-12-31 | 2016-04-19 | Calla Therapeutics Llc | Topical formulations of Flucytosine |
CA2719786A1 (en) | 2008-03-28 | 2009-10-01 | Glaxosmithkline Llc | Methods of treatment |
WO2009146104A1 (en) | 2008-04-02 | 2009-12-03 | Accentia Biopharmaceuticals, Inc. | Formulations, devices and methods for treating and preventing mucositis |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
CN102014957B (zh) | 2008-04-21 | 2014-12-10 | 奥德纳米有限公司 | 用于治疗耳部疾病和病况的耳用调配物 |
US8030297B2 (en) | 2008-05-14 | 2011-10-04 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders |
US8318817B2 (en) | 2008-07-21 | 2012-11-27 | Otonomy, Inc. | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
JP5839189B2 (ja) * | 2008-07-21 | 2016-01-06 | オトノミ—,インク. | 耳の不調の治療用の制御放出性の抗菌性組成物および方法 |
US8580801B2 (en) * | 2008-07-23 | 2013-11-12 | Robert I. Henkin | Phosphodiesterase inhibitor treatment |
US8763222B2 (en) | 2008-08-01 | 2014-07-01 | Intersect Ent, Inc. | Methods and devices for crimping self-expanding devices |
CN106039547A (zh) | 2009-05-15 | 2016-10-26 | 因特尔赛克特耳鼻喉公司 | 可展开装置及其使用方法 |
WO2011100170A1 (en) * | 2010-02-10 | 2011-08-18 | Albert Cha | Nasal irrigation systems |
US20120003300A1 (en) * | 2010-06-30 | 2012-01-05 | Pangaea Laboratories Ltd | Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
US9669044B2 (en) | 2010-12-14 | 2017-06-06 | Utah State University | Aminoglycoside and azole compositions and methods |
CN104105472A (zh) * | 2011-12-20 | 2014-10-15 | 维奥姆生物科学有限公司 | 用于治疗真菌感染的局部油组合物 |
SI2852391T1 (sl) | 2012-05-21 | 2022-04-29 | Insmed Incorporated | Sistemi za obravnavo pljučnih infekcij |
JP6529438B2 (ja) | 2012-11-29 | 2019-06-12 | インスメッド インコーポレイテッド | 安定化されたバンコマイシン処方物 |
WO2014151963A2 (en) | 2013-03-14 | 2014-09-25 | Intersect Ent, Inc. | Systems, devices, and method for treating a sinus condition |
WO2014186804A2 (en) * | 2013-05-17 | 2014-11-20 | Utah State University | Aminoglycoside and azole compositions and methods |
CN104208701A (zh) * | 2013-05-29 | 2014-12-17 | 天津金耀集团有限公司 | 含有抗真菌药物的复方吸入制剂 |
FR3009622B1 (fr) * | 2013-08-09 | 2015-08-07 | Novacyt | Procede et dispositif de lavage d'un dispositif de pipetage-distribution |
MX2016002408A (es) | 2013-08-27 | 2016-10-28 | Otonomy Inc | Metodos para el tratamiento de trastornos oticos pediatricos. |
CN106233141B (zh) | 2014-02-18 | 2018-08-21 | 罗伯特·I·汉金 | 用于诊断和治疗味觉或嗅觉的损失和/或失真的方法和组合物 |
EP3466432B1 (en) | 2014-05-15 | 2020-07-08 | Insmed Incorporated | Methods for treating pulmonary non-tuberculous mycobacterial infections |
BR112017010439B1 (pt) * | 2014-11-21 | 2023-03-07 | F2G Limited | Composto, composição farmacêutica, combinação farmacêutica, kit, métodos para controle de uma doença fúngica em uma planta, e, uso de um composto, de uma composição ou de uma combinação |
CN113679931A (zh) | 2015-01-22 | 2021-11-23 | 因特尔赛克特耳鼻喉公司 | 药物涂覆的气囊 |
US20180071281A1 (en) * | 2016-08-19 | 2018-03-15 | Gerbe Labs Inc. | Treating chronic rhinosinusitis |
EP3512513A4 (en) | 2016-09-16 | 2020-04-15 | Otonomy, Inc. | GEL FORMULA FOR THE EAR FOR TREATING OTITIS EXTERNA |
JP7295038B2 (ja) | 2017-06-06 | 2023-06-20 | グラクソスミスクライン エルエルシー | 小児患者のための生物薬剤組成物及び方法 |
EP3768270A4 (en) * | 2018-03-19 | 2021-12-08 | Sheo Pharmaceuticals | METHODS AND COMPOSITIONS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
CN111249219B (zh) * | 2018-11-30 | 2023-08-11 | 中南大学湘雅三医院 | 治疗耳道真菌的滴耳液及其制备方法 |
AU2020229360A1 (en) * | 2019-02-27 | 2021-08-19 | Oticara, Inc. | Method for treating nasal, sinonasal, and nasopharyngeal tissue infection and/or inflammation |
US11819503B2 (en) | 2019-04-23 | 2023-11-21 | F2G Ltd | Method of treating coccidioides infection |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
DE2350315C2 (de) * | 1973-10-06 | 1984-01-12 | Johnson & Johnson GmbH, 4000 Düsseldorf | Pharmazeutische und kosmetische Präparate zur äußerlichen Anwendung |
US4209447A (en) | 1975-01-27 | 1980-06-24 | Janssen Pharmaceutica N.V. | Imidazole derivatives and intermediates in their preparation |
US3991750A (en) | 1975-04-28 | 1976-11-16 | Syntex Corporation | Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals |
US4402957A (en) | 1979-04-04 | 1983-09-06 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of [4-(piperazin-1-ylphenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles |
US4334538A (en) | 1979-12-12 | 1982-06-15 | Juhn Steven K | Aspirator for collecting liquid samples |
US4432991A (en) | 1981-07-13 | 1984-02-21 | American Cyanamid Company | Therapeutically active 3-amino-1-phenyl(and substituted phenyl)-2-pyrazolines |
US4883785A (en) * | 1984-07-27 | 1989-11-28 | Chow Wing Sun | Complex of anti-fungal agent and cyclodextrin and method |
US4916134A (en) | 1987-03-25 | 1990-04-10 | Janssen Pharmacuetica N.V. | 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]me]phenyl]-1-piperazinyl]phenyl]triazolones |
US5487739A (en) | 1987-11-17 | 1996-01-30 | Brown University Research Foundation | Implantable therapy systems and methods |
US5075309A (en) | 1989-06-09 | 1991-12-24 | Janssen Pharmaceutica N.V. | Antifungal 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]triazolones and imidazolones |
US5080899A (en) | 1991-02-22 | 1992-01-14 | American Home Products Corporation | Method of treating pulmonary inflammation |
US5310545A (en) * | 1991-04-11 | 1994-05-10 | Drore Eisen | Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter |
US5248504A (en) | 1992-03-02 | 1993-09-28 | Friedman William H | Method of treatment for nasal and sinus dysfunction |
ES2170074T3 (es) | 1992-09-10 | 2002-08-01 | Childrens Medical Center | Matrices de polimero biodegradables para la liberacion prolongada de agentes anestesicos locales. |
CA2106034A1 (en) | 1992-09-24 | 1994-03-25 | Ralph J. Russo | 21-norrapamycin |
JP3918119B2 (ja) | 1993-01-21 | 2007-05-23 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 局所用ケトコナゾール組成物 |
RU2128053C1 (ru) | 1993-03-19 | 1999-03-27 | Налепо Лидия Филимоновна | Средство для лечения бронхиальной астмы (варианты) |
PH31594A (en) | 1993-09-30 | 1998-11-03 | Janssen Pharmaceutica Nv | Oral formulations on an antifungal. |
US5582167A (en) | 1994-03-02 | 1996-12-10 | Thomas Jefferson University | Methods and apparatus for reducing tracheal infection using subglottic irrigation, drainage and servoregulation of endotracheal tube cuff pressure |
US5952314A (en) * | 1994-04-01 | 1999-09-14 | Demichele; Stephen Joseph | Nutritional product for a person having ulcerative colitis |
EP0771205A2 (de) * | 1994-06-28 | 1997-05-07 | Dr. Zerle Gmbh | Neue klinische anwendungen von polyen-makroliden |
US5599795A (en) * | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
US5658881A (en) | 1994-10-14 | 1997-08-19 | Twk, Inc. | Method for topical inhibition of the metabolic activity of cytochrome P450 |
US5679648A (en) * | 1994-11-30 | 1997-10-21 | The University Hospital | Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides |
US5614206A (en) | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
JP3434396B2 (ja) * | 1995-06-30 | 2003-08-04 | 株式会社日立ユニシアオートモティブ | 鼻腔用投薬器 |
GB9514878D0 (en) | 1995-07-20 | 1995-09-20 | Danbiosyst Uk | Vitamin E as a solubilizer for drugs contained in lipid vehicles |
DE19541815B4 (de) * | 1995-11-09 | 2008-04-10 | Bannert, Christian, Dr. | Verwendung einer Lösung von Polyethylenglykol in Wasser als wässrige Spüllösung zur Prävention oder Behandlung von zähem Schleim, der in Verbindung mit Strahlen- oder/und Chemotherapie-induzierten Erkrankungen der Schleimhäute auftritt |
US5756127A (en) | 1996-10-29 | 1998-05-26 | Wright Medical Technology, Inc. | Implantable bioresorbable string of calcium sulfate beads |
RU2139707C1 (ru) | 1996-12-24 | 1999-10-20 | ОАО Нижегородский химико-фармацевтический завод | Суппозитории, обладающие противогрибковым действием (варианты) |
PT1024814E (pt) * | 1997-10-22 | 2007-11-29 | Mayo Foundation | Utilização de agentes antifúngicos para o tratamento tópico de mucosite induzida por fungo |
US5897872A (en) | 1997-11-12 | 1999-04-27 | Picciano; Dante J. | Iodine-containing nasal moisturizing saline solution |
EP1051129B1 (en) | 1998-01-30 | 2006-04-05 | Wilk Patent Development Corporation | Transmyocardial coronary artery bypass and revascularization |
-
1998
- 1998-10-22 PT PT98955065T patent/PT1024814E/pt unknown
- 1998-10-22 US US09/177,273 patent/US6291500B2/en not_active Expired - Fee Related
- 1998-10-22 CN CNB988123959A patent/CN1143679C/zh not_active Expired - Fee Related
- 1998-10-22 HU HU0004170A patent/HUP0004170A3/hu unknown
- 1998-10-22 DK DK98955065T patent/DK1024814T3/da active
- 1998-10-22 ID IDW20000973A patent/ID26104A/id unknown
- 1998-10-22 KR KR1020007004368A patent/KR20010031363A/ko active Search and Examination
- 1998-10-22 BR BR9814615-7A patent/BR9814615A/pt not_active Application Discontinuation
- 1998-10-22 US US09/177,659 patent/US20020052390A1/en not_active Abandoned
- 1998-10-22 SK SK573-2000A patent/SK5732000A3/sk unknown
- 1998-10-22 US US09/176,990 patent/US6207703B1/en not_active Expired - Lifetime
- 1998-10-22 JP JP2000516659A patent/JP2001520188A/ja not_active Withdrawn
- 1998-10-22 KR KR1020057022219A patent/KR100883149B1/ko not_active IP Right Cessation
- 1998-10-22 US US09/177,164 patent/US20010006944A1/en not_active Abandoned
- 1998-10-22 AU AU11959/99A patent/AU1195999A/en not_active Abandoned
- 1998-10-22 TR TR2000/01117T patent/TR200001117T2/xx unknown
- 1998-10-22 KR KR1020077012909A patent/KR20070069220A/ko not_active Application Discontinuation
- 1998-10-22 AP APAP/P/2000/001805A patent/AP2000001805A0/en unknown
- 1998-10-22 WO PCT/US1998/022403 patent/WO1999020261A2/en active IP Right Grant
- 1998-10-22 EP EP98955065A patent/EP1024814B1/en not_active Expired - Lifetime
- 1998-10-22 IL IL13577498A patent/IL135774A0/xx active IP Right Grant
- 1998-10-22 AT AT98955065T patent/ATE371457T1/de not_active IP Right Cessation
- 1998-10-22 DE DE69838338T patent/DE69838338T2/de not_active Expired - Lifetime
- 1998-10-22 EP EP07016335A patent/EP1857113A3/en not_active Withdrawn
- 1998-10-22 EA EA200000439A patent/EA200000439A1/ru unknown
- 1998-10-22 PL PL98340606A patent/PL340606A1/xx unknown
- 1998-10-22 KR KR1020067009173A patent/KR20060066753A/ko not_active Application Discontinuation
- 1998-10-22 EE EEP200000253A patent/EE200000253A/xx unknown
- 1998-10-22 ES ES98955065T patent/ES2292210T3/es not_active Expired - Lifetime
- 1998-10-22 CA CA2308201A patent/CA2308201C/en not_active Expired - Fee Related
-
2000
- 2000-02-08 US US09/500,115 patent/US20030091510A1/en not_active Abandoned
- 2000-04-19 IL IL135774A patent/IL135774A/en not_active IP Right Cessation
- 2000-04-19 IS IS5463A patent/IS5463A/is unknown
- 2000-04-19 NO NO20002069A patent/NO325714B1/no not_active IP Right Cessation
- 2000-04-20 OA OA1200000119A patent/OA11351A/en unknown
- 2000-04-24 BG BG104371A patent/BG104371A/xx unknown
-
2001
- 2001-02-06 HK HK01100853A patent/HK1029935A1/xx not_active IP Right Cessation
- 2001-05-25 US US09/865,785 patent/US6555566B2/en not_active Expired - Lifetime
-
2002
- 2002-11-13 US US10/293,924 patent/US20030153516A1/en not_active Abandoned
-
2004
- 2004-10-08 US US10/962,196 patent/US20050124561A1/en not_active Abandoned
-
2005
- 2005-12-27 JP JP2005375253A patent/JP2006096770A/ja not_active Withdrawn
-
2006
- 2006-07-26 JP JP2006202740A patent/JP2007008951A/ja active Pending
-
2009
- 2009-05-13 US US12/465,394 patent/US20090253645A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004170A2 (hu) | Eljárás és anyagok nyálkaszövetek gyulladásának kezelésére és megelőzésére | |
RU94038043A (ru) | Применение замещенных производных аденина для лечения множественного склероза | |
TNSN04113A1 (en) | 3-â-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF | |
EP1140170A4 (en) | NOVEL AGENTS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF EYE DISORDERS | |
KR960700742A (ko) | 아토피성질환 치료약(atopic disease remedy) | |
EA200000608A1 (ru) | Предотвращение и лечение амилоидогенного заболевания | |
ATE297204T1 (de) | Heilmittel für neurodegenerative krankheiten | |
EP1390491A4 (en) | METHOD OF TREATING NEURODEGENERATIVE, PSYCHIATRIC AND OTHER DISEASES WITH DEACETYLASE INHIBITORS | |
DE69400799D1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
MX9605650A (es) | Formulaciones de propionato de fluticasona. | |
BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
ATE207352T1 (de) | Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen | |
DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
KR960703009A (ko) | 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용 | |
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
DK0735877T3 (da) | 6-(2-imidazolinylamino)quinoxalinforbindelser, der er egnede som alfa-2-adrenoceptoragonister. | |
DE60231131D1 (de) | Vakzine und verwendung davon zur behandlung amyotrophischer lateralsklerose | |
ATE169225T1 (de) | Anwendung von urodilatin bei lungen- und bronchialerkrankungen | |
AU5116298A (en) | The use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with BDV infections in humans and animals | |
NO982989L (no) | Anvendelse av inhibitorer av den cellulµre Na+/H+-utbytteren (NHE) for fremstilling av et medikament for respiratorstimulering | |
BR0310061A (pt) | Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições | |
RS8504A (en) | Novel cyclohexil sulphones | |
RU94040886A (ru) | Применение производных мелатонина для лечения нарушений сна, фармацевтическая композиция | |
AP1896A (en) | The method of treating cancer |